The Federal Trade Commission has finalized a consent order against Vanilla Chip LLC, which marketed children’s supplements under the TruHeight name, after alleging the company used deceptive tactics to sell supposed height-enhancing products for kids and teens. The final order resolves an enforcement action first announced in April 2026 and centers on claims that TruHeight could increase children’s height without adequate scientific support. For parents weighing growth supplements against medical advice, the case shows how aggressive marketing and fake online endorsements can distort what looks like trustworthy health information.
Why The FTC finalized action against childrens supplement matters now
The enforcement reached a key milestone when the FTC approved a final order against TruHeight resolving allegations that had been pending since earlier this year, according to an FTC press release. That order closes the agency’s case but also sets out ongoing obligations for TruHeight, which the FTC identified as Vanilla Chip LLC, matter number 242-3093, in its case docket. The agency’s decision signals that it is prepared to carry health marketing disputes involving children’s products all the way from complaint to final consent order rather than relying on informal warnings.
The stakes are direct for families. The FTC alleged that TruHeight marketed supplements for kids and teens since at least 2020 with promises that the products could increase height, according to an FTC business guidance blog. Parents often encounter such claims when searching online for help with a child’s growth, and the case shows how those claims can be amplified by reviews and testimonials that are not what they appear to be.
The agency’s own framing of the case makes clear that this is not only about unproven health benefits but also about how digital platforms can be manipulated. The FTC alleged that TruHeight used employee and vendor reviews, incentivized customer reviews, fake social media profiles, and bots to promote its supplements, according to the July press release on the final order. Those tactics speak directly to the hypothesis that consent orders citing incentivized reviews and bot activity could affect sales on the platforms where such tactics were most visible, because they remove tools that can quickly inflate a product’s apparent popularity.
Whether that hypothesis bears out will depend on how platforms and consumers react. If retailers and review sites adjust their own policies in response to FTC enforcement, or if parents become more skeptical of glowing testimonials for children’s supplements, similar products could see lower conversion rates even without new agency actions. The TruHeight case gives regulators a concrete example they can point to when they warn other supplement marketers about paid or fabricated endorsements.
The evidence behind The FTC finalized action against childrens supplement
The FTC’s record in the TruHeight matter is anchored in its complaint, consent agreement, and final decision, which are cataloged under matter number 242-3093 on the agency’s case timeline. Those documents identify the company as Vanilla Chip LLC doing business as TruHeight and describe how the supplements were marketed to parents of children and teenagers. The agency stated that TruHeight had been selling and promoting its products since at least 2020, a period that covers multiple school years and growth cycles for the children targeted by the ads.
According to the FTC’s April announcement of the proposed settlement, TruHeight made unsubstantiated claims that its supplements could increase height in kids and teens, and it told consumers the products were “clinically proven” to do so. Those allegations were laid out when the FTC first announced its action against the company. The business guidance blog expands on that description, explaining that the company used testimonials that implied the supplements had caused specific height increases, even though the agency alleged that TruHeight lacked adequate scientific evidence to back those claims.
The FTC’s July press release on the final order describes a second core set of allegations: how TruHeight built a misleading online reputation for its products. The agency stated that TruHeight used employee reviews, vendor reviews, and incentivized reviews to promote its supplements, presenting these as if they were independent consumer opinions. The same release alleges that the company used fake social media profiles and bots to boost its marketing, creating an artificial sense of buzz around the products.
In its business guidance blog, the FTC framed the TruHeight case as an example of its broader effort to protect children from deceptive and unsubstantiated health claims. The blog explains that the agency is concerned not only with the content of health claims but also with how endorsements and reviews are presented, especially when they suggest causation such as a child gaining a certain amount of height after using a product. By citing employee and incentivized reviews in the TruHeight matter, the agency signaled that it views hidden financial ties and fabricated personas as central evidence, not side issues.
The public record also shows how the FTC processed the case procedurally. The proposed consent order was subject to a public comment period, as indicated in a notice titled “Analysis of Proposed Consent Order To Aid Public Comment” that appears in the Federal Register. That analysis described the purpose of the consent order and invited comments through the regulations.gov docket, which is referenced in the FTC’s case materials. After considering any comments, the Commission approved the final order that now governs TruHeight’s conduct.
What remains unresolved for The FTC finalized action against childrens supplement
Even with a final order in place, several aspects of the TruHeight case remain opaque to the public. The FTC’s press releases and blog posts do not quantify how many families bought TruHeight supplements or how much money changed hands while the alleged deceptive practices were in place. Insufficient data to determine the volume of sales linked to employee, vendor, incentivized reviews, or bot activity appears in the available sources, which limits any attempt to measure how much these tactics affected consumer behavior.
The April press release on the proposed settlement refers to a monetary judgment with partial suspension based on TruHeight’s claimed inability to pay, but it does not list the dollar amount or the financial details that led the agency to accept a suspended judgment. Insufficient data to determine the exact size of the judgment or the company’s financial condition appears in the documents summarized in the public-facing materials. That leaves open questions about how much financial recovery consumers might see compared with the amount they spent on the supplements.
The sources also do not include direct statements from TruHeight executives or customers. The FTC’s materials present the agency’s allegations and legal conclusions but do not reproduce any response from Vanilla Chip LLC beyond the company’s agreement to the consent order. As a result, there is no public explanation from the company about why it used the reviews and marketing tactics described by the FTC or how it views the scientific support for its products.
For the broader supplement market, the unresolved issue is whether cases like TruHeight will change how similar products are sold on major online platforms. The FTC’s hypothesis-driven enforcement around fake reviews and bots suggests that other marketers that rely on aggressive testimonial campaigns could face scrutiny, but the agency has not yet published data connecting such consent orders to measurable sales declines. Insufficient data to determine any correlation between the TruHeight order and sales trends for competing supplements appears in the current record.
For readers, the immediate takeaway is practical. Parents who see bold claims about height growth for kids and teens have reason to ask whether those claims are backed by solid clinical evidence and whether the glowing reviews come from real, independent customers. The FTC encourages consumers who suspect deceptive practices to report them through tools such as ReportFraud.ftc.gov, which feeds into investigations like the TruHeight case. The next development to watch is whether the agency brings similar actions against other children’s supplement brands that blend health promises with manipulated online endorsements.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
